Tetrazines/trans-cyclooctenes in solid phase synthesis of labeled peptides
US-2015359913-A1 · Dec 17, 2015 · US
Radioactive fluorine-labeled compound
US9107964B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9107964-B2 |
| Application number | US-201214345493-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 18, 2012 |
| Priority date | Sep 22, 2011 |
| Publication date | Aug 18, 2015 |
| Grant date | Aug 18, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention is a compound represented by the following formula (1) or a salt thereof. In the formula (1), R 1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound represented by the following formula (1) or a salt thereof, wherein in the formula (1), R 1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2. 2. A compound represented by the following formula (2) or a salt thereof,…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- A61K51/0453Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9107964B2 cover?
- The present invention is a compound represented by the following formula (1) or a salt thereof. In the formula (1), R 1 denotes a hydrogen atom, a methyl group, or a hydroxymethyl group, and n is an integer of 1 or 2.
- Who is the assignee on this patent?
- Nihon Mediphysics Co Ltd, Univ Hokkaido Nat Univ Corp
- What technology area does this patent fall under?
- Primary CPC classification A61K51/0453. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).